Literature DB >> 8538330

Efficacy of risperidone in idiopathic segmental dystonia.

A Zuddas, C Cianchetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8538330     DOI： 10.1016/s0140-6736(96)90257-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Current and future medical treatment in primary dystonia.

Authors:  Cathérine C S Delnooz; Bart P C van de Warrenburg
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

Review 2.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Treatment strategies for dystonia.

Authors:  Leslie J Cloud; H A Jinnah
Journal:  Expert Opin Pharmacother       Date:  2010-01       Impact factor: 3.889

Review 4.  Primary blepharospasm: diagnosis and management.

Authors:  Giovanni Defazio; Paolo Livrea
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Managing antipsychotic-induced acute and tardive dystonia.

Authors:  M Raja
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.